期刊文献+

鱼油脂肪乳剂和中长链脂肪乳剂对肠衰竭相关肝损害患儿肝功能的影响研究 被引量:3

Effects of a fish oil lipid emulsion versus a MCT/LCT lipid emulsion on intestinal failure associated liver disease in children
下载PDF
导出
摘要 目的比较鱼油脂肪乳剂和中长链脂肪乳剂对肠衰竭相关肝损害患儿肝功能的影响。方法回顾性分析上海交通大学医学院附属新华医院1999年1月至2017年5月65例接受肠外营养肠衰竭患儿的临床资料。患儿最初均采用中长链脂肪乳剂(按患儿体重计算,平均剂量1.2g/kg)进行治疗,此时肝功能各项指标正常,当TBA、ALT、AST、AKP、γ-GT、Tbi、Dbi中任何3项高于正常参考值范围2倍水平时进行干预方案调整,本组中有31例更换为鱼油脂肪乳剂(按患儿体重计算,平均剂量1g/kg)治疗,余34例继续应用中长链脂肪乳剂治疗。治疗过程中每周监测一次肝功能。结果鱼油脂肪乳剂组ALT、γ-GT、Tbi水平均显著下降(P<0.05),而中长链脂肪乳剂组仅AST、Tbi水平出现下降(P<0.05)。两组对比结果显示,干预前鱼油脂肪乳剂组ALT、Dbi水平显著高于中长链脂肪乳剂组(P<0.05),干预后两组肝功能指标均无显著差异(P>0.05)。鱼油脂肪乳剂组肝功能恢复正常时间的中位数为22(17~32)d,中长链脂肪乳剂组肝功能恢复正常时间的中位数为28(15~52.5)d,两者比较差异具有统计学意义(P<0.05)。结论相比于中长链脂肪乳剂,鱼油脂肪乳剂更有助于减轻小儿肠衰竭相关肝损害程度。 Objective To compare the effects of fish oil(FO)lipids with medium-long chain(MCT/LCT)lipids on intestinal failure associated liver disease(IFALD)in children. Methods We enrolled 65 children with intestinal failure for long-term parenteral nutrition(PN)from Xinhua Hospital from January 1999 through May 2017.All children initially received MCT/LCT lipids(based on body weight with an average daily dose of 1.2 g/kg).Liver function was normal at that time.The levels of any three of measurements of total bile acid(TBA),alanine transaminase(ALT),aspartate transaminase(AST),alkaline phosphatase(AKP),gamma glutamyl transferase(γ-GT),total bilirubin(Tbi)or direct bilirubin(Dbi)were two folds higher than normal levels during PN.Thirty-one patients were switched lipids into FO lipids(based on body weight with an average daily dose of 1g/kg)and 34 patients continued MCT/LCT lipids.And liver function was monitored weekly during treatment. Results ALT,γ-GT and Tbi markedly decreased in FO group( P <0.05).In MCT/LCT group,only the serum levels of AST and Tbi declined( P <0.05).Comparison results of two groups: Before treatment,ALT and Dbi markedly increased in FO group( P <0.05),but the liver function was no significant differance after treatment( P >0.05). The median time to reversal of liver dysfunction was 22(17-32)days in FO group and 28(15-52.5)days in MCT/LCT group( P <0.05). Conclusion Fish oil lipids may alleviate IFALD in children.
作者 黄柳芳 王楠 张天 颜伟慧 陆丽娜 陶怡菁 蔡威 王莹 Huang Liufang;Wang Nan;Zhang Tian;Yan Weihui;Lu Lina;TaoYijing;Cai Wei;Wang Ying(Department of Pediatric Gastroenterology & Nutrition,Xin Hua Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200092,China;Department of Pediatric Surgery,Affiliated Xinhua Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200092,China;Shanghai Institute of Pediatric Research,Shanghai 200092,China;Shanghai Key Laboratory of Pediatric Gastroenterology & Nutrition,Shanghai 200092,China)
出处 《临床小儿外科杂志》 CAS 2019年第9期752-756,共5页 Journal of Clinical Pediatric Surgery
基金 国家自然科学基金项目(编号:81974066) 浦江人才计划项目(编号:17PJD026) 上海市小儿消化与营养重点实验室项目(编号:17DZ2272000) 上海交通大学医学院紧缺专业硕士研究生临床研究能力提升计划资助(编号:JQ201802)
关键词 鱼油 肠衰竭相关肝损害 胃肠外营养 Fish Oils Intestinal Failure Associated Liver Disease Parenteral Nutrition
  • 相关文献

参考文献1

二级参考文献19

  • 1Freund HR. Abnormalities of liver function and hepatic damage associated with total parenteral nutrition. Nutrition, 1991,7 (1) : 1-5, discussion 5-6.
  • 2Kelly DA. Intestinal failure-associated liver disease:what do we know today .9 Gastroenterology,2006,130 ( 2 Suppl 1 ) : $70 -77.
  • 3Carter BA, Shulman RJ. Mechanisms of disease : update on the molecular etiology and fundamentals of parenteral nutrition associ- ated cholestasis. Nat Clin Pract Gastroenterol Hepatol, 2007,4 (5) :277-287.
  • 4Llop JM, Virgili N, Moreno-Villares JM, et al. Phytosterolemia in parenteral nutrition patients:implications for liver disease devel- opment. Nutrition,2008,24 (11-12) : 1145-1152.
  • 5Alwayn IP, Gura K, Nose V, et al. Omega-3 fatty acid supplemen-tation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res,2005,57 ( 3 ) :445-452.
  • 6Diamond IR,Sterescu A, Pencharz PB, et al. Changing the para- digm:omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr, 2009,48 ( 2 ) : 209- 215.
  • 7de Meijer VE, Le HD, Meisel JA, et al. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr,2010, 50(2) :212-218.
  • 8Puder M, Valim C, Meisel JA, et al. Parenteral fish oil Improves outcomes in patients with parenteral nutrition-associated liver In- jury. Ann Surg,2009,250 ( 3 ) : 395-402.
  • 9Lee SI, Valim C, Johnston P, et al. Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res,2009,66(6) :698-703.
  • 10Gura KM,Lee S,Valim C, et al. Safety and efficacy of a fish-oil- based fat emulsion in the treatment of parenteral nutrition-associ- ated liver disease. Pediatrics ,2008,121 (3) :e678-686.

共引文献20

同被引文献19

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部